Celestica, Inc. (CLS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CLS SEC filings page.
Celestica, Inc. (CLS) reported $15.6B in revenue over the twelve months to Jun 30, 2026, up 47.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Celestica's scale-up is increasingly converting sales into profit, with margins widening as overhead grows more slowly than revenue.
From FY2023 to FY2025, revenue nearly doubled while operating margin rose from4.3% to8.4% , indicating that incremental volume is being absorbed with better cost efficiency rather than merely adding sales. Yet FY2025 operating cash flow of$659.5M remained below net income of$832.5M , while inventory also increased, linking the cash gap to more capital tied up in operations.
The improvement reaches beyond operating profit: gross margin climbed from
The balance sheet expanded without a parallel rise in leverage: debt-to-equity eased from 0.4x in FY2024 to 0.3x in FY2025, even as assets increased. Current ratio stayed near 1.4x, suggesting working-capital needs remain material without a major change in short-term liquidity.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Celestica, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Celestica, Inc. has an operating margin of 8.4%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 60/100, indicating healthy but not exceptional operating efficiency. This is up from 6.2% the prior year.
Celestica, Inc.'s revenue surged 28.5% year-over-year to $12.4B, reflecting rapid business expansion. This strong growth earns a score of 86/100.
Celestica, Inc. carries a low D/E ratio of 0.34, meaning only $0.34 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.
Celestica, Inc.'s current ratio of 1.44 indicates adequate short-term liquidity, earning a score of 39/100. The company can meet its near-term obligations, though with limited headroom.
Celestica, Inc. has a free cash flow margin of 3.7%, earning a moderate score of 38/100. The company generates positive cash flow after capital investments, but with room for improvement.
Celestica, Inc. earns a strong 37.6% return on equity (ROE), meaning it generates $38 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 84/100. This is up from 22.6% the prior year.
Celestica, Inc. scores 7.16, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($38.3B) relative to total liabilities ($5.0B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Celestica, Inc. passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Celestica, Inc. generates $0.79 in operating cash flow ($659.5M OCF vs $832.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Celestica, Inc. earns $19.79 in operating income for every $1 of interest expense ($1.0B vs $52.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Celestica, Inc. generated $4.7B in revenue in Q2 2026. This represents an increase of 62.4% from the same quarter a year earlier. Against the prior quarter it is up 16.1%.
Celestica, Inc.'s EBITDA was $502.3M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 58.1% from the same quarter a year earlier. Against the prior quarter it is up 61.1%.
Celestica, Inc. reported $368.8M in net income in Q2 2026. This represents an increase of 74.8% from the same quarter a year earlier. Against the prior quarter it is up 73.7%.
Celestica, Inc. earned $3.17 per diluted share (EPS) in Q2 2026. This represents an increase of 74.2% from the same quarter a year earlier. Against the prior quarter it is up 73.2%.
Cash & Balance Sheet
Celestica, Inc. generated $147.1M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 22.7% from the same quarter a year earlier. Against the prior quarter it is up 16.0%.
Celestica, Inc. held $535.7M in cash against $784.0M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Celestica, Inc.'s gross margin was 12.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.
Celestica, Inc.'s operating margin was 9.8% in Q2 2026, reflecting core business profitability. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.0 percentage points.
Celestica, Inc.'s net profit margin was 7.8% in Q2 2026, showing the share of revenue converted to profit. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.6 percentage points.
Celestica, Inc.'s ROE was 14.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.8 percentage points.
Capital Allocation
Celestica, Inc. invested $46.3M in research and development in Q2 2026. This represents an increase of 36.2% from the same quarter a year earlier. Against the prior quarter it is up 12.4%.
Celestica, Inc. repurchased no shares in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Celestica, Inc. invested $263.8M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 711.7% from the same quarter a year earlier. Against the prior quarter it is up 14.9%.
CLS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7B+62.4% | $4.0B+52.8% | $3.7B+43.6% | $3.2B+27.8% | $2.9B+21.0% | $2.6B+19.9% | $2.5B | $2.5B |
| Cost of Revenue | $4.1B+63.4% | $3.6B+52.0% | $3.2B+43.3% | $2.8B+24.1% | $2.5B+18.0% | $2.4B+19.5% | $2.2B | $2.2B |
| Gross Profit | $577.5M+55.7% | $437.2M+59.6% | $433.1M+45.7% | $416.1M+59.7% | $371.0M+46.2% | $273.9M+23.3% | $297.2M | $260.6M |
| R&D Expenses | $46.3M+36.2% | $41.2M+134.1% | $30.2M+29.1% | $36.4M+94.7% | $34.0M+75.3% | $17.6M+6.7% | $23.4M | $18.7M |
| SG&A Expenses | $58.1M+49.4% | $117.4M+4.4% | $70.1M+21.7% | $38.4M-58.2% | $38.9M-50.9% | $112.5M+73.6% | $57.6M | $91.8M |
| Operating Income | $458.3M+68.2% | $272.1M+111.3% | $314.4M+55.2% | $325.0M+135.5% | $272.5M+105.0% | $128.8M+2.4% | $202.6M | $138.0M |
| EBITDA | $502.3M+58.1% | $311.7M+87.5% | $367.1M+51.3% | $365.3M+106.0% | $317.8M+87.2% | $166.2M+2.9% | $242.6M | $177.3M |
| Interest Expense | $21.2M+47.2% | $16.0M+16.8% | $11.7M-1.7% | $12.8M+14.3% | $14.4M-4.0% | $13.7M-2.1% | $11.9M | $11.2M |
| Income Tax | $72.8M+57.2% | $44.0M+60.0% | $33.8M-10.6% | $43.1M+24.9% | $46.3M+150.3% | $27.5M+105.2% | $37.8M | $34.5M |
| Net Income | $368.8M+74.8% | $212.3M+146.3% | $267.5M+76.3% | $267.8M+199.2% | $211.0M+122.1% | $86.2M-6.1% | $151.7M | $89.5M |
| EPS (Basic) | $3.21+75.4% | $1.85+150.0% | $2.32+79.8% | $2.33+206.6% | $1.83+128.8% | $0.74-3.9% | $1.29 | $0.76 |
| EPS (Diluted) | $3.17+74.2% | $1.83+147.3% | $2.30+78.3% | $2.31+208.0% | $1.82+127.5% | $0.74-3.9% | $1.29 | $0.75 |
| Diluted Shares (Avg) | 116M+0.3% | 116M-1.0% | N/A | 116M-2.5% | 116M-2.9% | 117M-2.0% | N/A | 119M |
CLS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.8B+56.8% | $8.3B+41.6% | $7.2B+20.5% | $6.6B | $6.2B | $5.8B | $6.0B+1.7% | N/A |
| Current Assets | $7.6B+58.8% | $6.4B+46.2% | $5.7B+25.7% | $5.1B | $4.8B | $4.4B | $4.5B0.0% | N/A |
| Cash & Equivalents | $535.7M+70.7% | $378.0M+24.8% | $595.6M+40.7% | $305.9M-23.2% | $313.8M-27.7% | $303.0M-1.7% | $423.3M+14.3% | $398.5M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $3.4B+77.3% | $2.7B+49.5% | $2.2B+24.3% | $2.0B | $1.9B | $1.8B | $1.8B-16.3% | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $332.9M-2.3% | $333.0M-2.2% | $333.1M-2.2% | $340.7M | $340.8M | $340.5M | $340.5M+5.8% | N/A |
| Total Liabilities | $7.3B+63.0% | $6.2B+44.0% | $5.0B+22.1% | $4.6B | $4.5B | $4.3B | $4.1B-0.7% | N/A |
| Current Liabilities | $6.2B+86.1% | $5.1B+66.3% | $3.9B+30.4% | $3.5B | $3.3B | $3.1B | $3.0B-6.2% | N/A |
| Non-Current Liabilities | $1.1B-2.9% | $1.1B-11.7% | $1.1B-1.3% | $1.1B | $1.2B | $1.2B | $1.1B+19.1% | N/A |
| Long-Term Debt | $784.0M-7.6% | $746.5M-18.4% | $750.5M-2.6% | $756.7M | $848.6M | $915.0M | $770.2M+18.8% | N/A |
| Total Equity | $2.5B+41.1% | $2.1B+34.8% | $2.2B+16.9% | $2.0B+11.8% | $1.8B-2.3% | $1.6B-8.9% | $1.9B+7.1% | $1.8B |
| Retained Earnings | N/A | N/A | $408.7M+196.4% | N/A | N/A | N/A | -$423.8M+50.2% | N/A |
Not reported in any period shown, so not listed: Accounts Receivable.
CLS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $410.9M+169.6% | $356.3M+173.4% | $250.6M+74.8% | $126.2M+2.8% | $152.4M+53.0% | $130.3M+20.5% | $143.4M | $122.8M |
| Depreciation & Amortization | $44.0M-2.9% | $39.6M+5.9% | $52.7M+31.8% | $40.3M+2.5% | $45.3M+22.8% | $37.4M+4.8% | $40.0M | $39.3M |
| Stock-Based Compensation | $19.3M+27.0% | $30.5M+17.3% | N/A | $15.6M+22.8% | $15.2M+27.7% | $26.0M+14.5% | N/A | $12.7M |
| Capital Expenditures | $263.8M+711.7% | $229.5M+525.3% | $94.7M+98.9% | $37.3M-18.9% | $32.5M-11.9% | $36.7M-9.2% | $47.6M | $46.0M |
| Free Cash Flow | $147.1M+22.7% | $126.8M+35.5% | $155.9M+62.7% | $88.9M+15.8% | $119.9M+91.2% | $93.6M+38.3% | $95.8M | $76.8M |
| Investing Cash Flow | -$266.3M-660.9% | -$218.4M-495.1% | -$94.7M-85.7% | -$37.3M+26.9% | -$35.0M+50.1% | -$36.7M+9.2% | -$51.0M | -$51.0M |
| Financing Cash Flow | $13.1M+112.3% | -$355.5M-66.2% | $133.8M+297.9% | -$96.8M+9.8% | -$106.6M-210.6% | -$213.9M-64.5% | -$67.6M | -$107.3M |
| Share Buybacks | $0-100.0% | $22.6M-70.9% | $35.7M+40.0% | $0-100.0% | $40.0M+300.0% | $77.7M+370.9% | $25.5M | $100.0M |
Not reported in any period shown, so not listed: Dividends Paid.
CLS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.3%-0.5pp | 10.8%+0.5pp | 11.8%+0.2pp | 13.0%+2.6pp | 12.8%+2.2pp | 10.3%+0.3pp | 11.7% | 10.4% |
| Operating Margin | 9.8%+0.3pp | 6.7%+1.9pp | 8.6%+0.6pp | 10.2%+4.7pp | 9.4%+3.9pp | 4.9%-0.8pp | 8.0% | 5.5% |
| Net Margin | 7.8%+0.6pp | 5.3%+2.0pp | 7.3%+1.4pp | 8.4%+4.8pp | 7.3%+3.3pp | 3.3%-0.9pp | 6.0% | 3.6% |
| Return on Equity | 14.9%+2.9pp | 10.1%+4.6pp | 12.1%+4.1pp | 13.2%+8.3pp | 12.0%+6.7pp | 5.5%+0.2pp | 8.0% | 4.9% |
| Return on Assets | 3.8%+0.4pp | 2.6%+1.1pp | 3.7%+1.2pp | 4.0% | 3.4% | 1.5% | 2.5% | N/A |
| Current Ratio | 1.23-0.2x | 1.26-0.2x | 1.44-0.1x | 1.47 | 1.44 | 1.43 | 1.49+0.1x | N/A |
| Debt-to-Equity | 0.32-0.2x | 0.36-0.2x | 0.34-0.1x | 0.37 | 0.48 | 0.59 | 0.410.0x | N/A |
| Asset Turnover | 0.480.0x | 0.490.0x | 0.51+0.1x | 0.48 | 0.46 | 0.45 | 0.43 | N/A |
| FCF Margin | 3.1%-1.0pp | 3.1%-0.4pp | 4.3%+0.5pp | 2.8%-0.3pp | 4.1%+1.5pp | 3.5%+0.5pp | 3.8% | 3.1% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Celestica, Inc. CLS | FY2025 | $12.4B | $832.5M | 6.7% | $38.3B | 64/100 |
| Jabil Inc. JBL | FY2025 | $29.8B | $657.0M | 2.2% | $29.2B | 49/100 |
| Flex Ltd. FLEX | FY2026 | $27.9B | $880.0M | 3.1% | $33.4B | 51/100 |
| Fabrinet FN | FY2026 | $4.6B | $473.0M | 10.2% | $13.0B | 69/100 |
| TE Connectivity plc TEL | FY2025 | $17.3B | $1.8B | 10.7% | $61.6B | 65/100 |
| Corning Incorporated GLW | FY2025 | $15.6B | $1.6B | 10.2% | $113.7B | 47/100 |
Where Celestica, Inc. Ranks
Frequently Asked Questions
What is Celestica, Inc.'s annual revenue?
Celestica, Inc. (CLS) reported $12.4B in total revenue for fiscal year 2025. This represents a 28.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Celestica, Inc.'s revenue growing?
Celestica, Inc. (CLS) revenue grew by 28.5% year-over-year, from $9.6B to $12.4B in fiscal year 2025.
Is Celestica, Inc. profitable?
Yes, Celestica, Inc. (CLS) reported a net income of $832.5M in fiscal year 2025, with a net profit margin of 6.7%.
What is Celestica, Inc.'s EBITDA?
Celestica, Inc. (CLS) had EBITDA of $1.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Celestica, Inc. have?
As of fiscal year 2025, Celestica, Inc. (CLS) had $595.6M in cash and equivalents against $750.5M in long-term debt.
What is Celestica, Inc.'s gross margin?
Celestica, Inc. (CLS) had a gross margin of 12.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Celestica, Inc.'s operating margin?
Celestica, Inc. (CLS) had an operating margin of 8.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Celestica, Inc.'s net profit margin?
Celestica, Inc. (CLS) had a net profit margin of 6.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Celestica, Inc.'s return on equity (ROE)?
Celestica, Inc. (CLS) has a return on equity of 37.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Celestica, Inc.'s free cash flow?
Celestica, Inc. (CLS) generated $458.3M in free cash flow during fiscal year 2025. This represents a 51.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Celestica, Inc.'s operating cash flow?
Celestica, Inc. (CLS) generated $659.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Celestica, Inc.'s total assets?
Celestica, Inc. (CLS) had $7.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Celestica, Inc.'s capital expenditures?
Celestica, Inc. (CLS) invested $201.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Celestica, Inc. spend on research and development?
Celestica, Inc. (CLS) invested $118.2M in research and development during fiscal year 2025.
What is Celestica, Inc.'s current ratio?
Celestica, Inc. (CLS) had a current ratio of 1.44 as of fiscal year 2025, which is considered adequate.
What is Celestica, Inc.'s debt-to-equity ratio?
Celestica, Inc. (CLS) had a debt-to-equity ratio of 0.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Celestica, Inc.'s return on assets (ROA)?
Celestica, Inc. (CLS) had a return on assets of 11.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Celestica, Inc.'s P/E ratio?
Celestica, Inc. (CLS) trades at 34.3x earnings, its market capitalization divided by net income of $1.1B net income, trailing 12 months to June 30, 2026. The market capitalization is $38.3B as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Celestica, Inc.'s price-to-sales ratio?
Celestica, Inc. (CLS) trades at 2.5x sales, its market capitalization divided by revenue of $15.6B revenue, trailing 12 months to June 30, 2026. The market capitalization is $38.3B as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Celestica, Inc.'s Altman Z-Score?
Celestica, Inc. (CLS) has an Altman Z-Score of 7.16, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Celestica, Inc.'s Piotroski F-Score?
Celestica, Inc. (CLS) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Celestica, Inc.'s earnings high quality?
Celestica, Inc. (CLS) has an earnings quality ratio of 0.79x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Celestica, Inc. cover its interest payments?
Celestica, Inc. (CLS) has an interest coverage ratio of 19.79x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Celestica, Inc.?
Celestica, Inc. (CLS) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.